相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
Marcos Pedrosa et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties
Feng Wang et al.
CELLS (2019)
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
Michelle L. Boland et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Inhibition of Non-Small Cell Lung Cancer Cells by Oxy210, an Oxysterol-Derivative that Antagonizes TGFβ and Hedgehog Signaling
Frank Stappenbeck et al.
CELLS (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice
Simon T. Hui et al.
HEPATOLOGY (2018)
Hedgehog signalling in liver pathophysiology
Mariana Verdelho Machado et al.
JOURNAL OF HEPATOLOGY (2018)
Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol
Feng Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Novel TGF-β inhibitors ready for prime time in onco-immunology
Armand de Gramont et al.
ONCOIMMUNOLOGY (2017)
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hannes Hagstrom et al.
JOURNAL OF HEPATOLOGY (2017)
Inflammation and metabolism in tissue repair and regeneration
Sabine A. Eming et al.
SCIENCE (2017)
Promising Therapy Candidates for Liver Fibrosis
Ping Wang et al.
FRONTIERS IN PHYSIOLOGY (2016)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Hepatic fibrosis: Concept to treatment
Christian Trautwein et al.
JOURNAL OF HEPATOLOGY (2015)
Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains
Brian J. Bennett et al.
PLOS GENETICS (2015)
The genetic architecture of NAFLD among inbred strains of mice
Simon T. Hui et al.
ELIFE (2015)
Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease
Mariana Verdelho Machado et al.
PLOS ONE (2015)
Embryofetal Development Study of Vismodegib, a Hedgehog Pathway Inhibitor, in Rats
Eric Morinello et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2014)
Association of adult weight gain and nonalcoholic fatty liver in a cross-sectional study in Wan Song Community, China
W. -J. Zhang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)
A Novel Osteogenic Oxysterol Compound for Therapeutic Development to Promote Bone Growth: Activation of Hedgehog Signaling and Osteogenesis Through Smoothened Binding
Scott R. Montgomery et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
Jason R. Clapper et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats
Hong Ling et al.
PLOS ONE (2013)
Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis
Petra Hirsova et al.
PLOS ONE (2013)
Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1
Xiaobao Fan et al.
PLOS ONE (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
TGF-β in progression of liver disease
Steven Dooley et al.
CELL AND TISSUE RESEARCH (2012)
Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro
Xiao-Ming Meng et al.
JOURNAL OF PATHOLOGY (2012)
Pathogenesis of Liver Fibrosis
Virginia Hernandez-Gea et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Nonalcoholic Fatty Liver Disease: A Review of the Spectrum of Disease, Diagnosis, and Therapy
Krzysztof Lukasz Kopec et al.
NUTRITION IN CLINICAL PRACTICE (2011)
Oxysterols pathway in are novel activators of the hedgehog pluripotent mesenchymal cells
Jennifer R. Dwyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction
Katsutaro Morino et al.
DIABETES (2006)
Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice
Z Mallat et al.
CIRCULATION RESEARCH (2001)
分享论文
